Type-specific human papillomavirus prevalence in women referred for colposcopy in Tehran

  • Rahim Soleimani-Jelodar Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Arash Arashkia Department of Virology, Pasteur Institute of Iran, Tehran, Iran
  • Zabihollah Shoja Department of Virology, Pasteur Institute of Iran, Tehran, Iran
  • Kimia Sharifian Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Setareh Akhavan Department of Gynecology Oncology, Imam Khomeini Hospital Complex, Valiasr Hospital Tehran, Iran
  • Fariba Yarandi Department of Obstetrics and Gynecology, Yas Hospital, Tehran, Iran
  • Somayeh Jalilvand Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Keywords: Human papillomavirus; Uterine cervical neoplasms; Cervical intraepithelial neoplasia; Atypical squamous cells of the cervix; Human papilloma virus vaccines

Abstract

Background and Objectives: Although several studies have been achieved on the frequency of the HPV types among wom- en with cervical cancer in Iran, HPV-positive samples were in some cases directed to specific-primer genotyping of HPV 16 and 18. Therefore, the other HPV types are underestimated. Several studies have also reported a greater prevalence of HPV 16 in cervical cancer in Iran than in the world. To clarify these subjects, the distribution of HPV types in women referred for colposcopy in Tehran was investigated.

Materials and Methods: In this cross-sectional study, a total of 148 cervical samples from women with normal, atypical squamous cells of undetermined significance, cervical intraepithelial neoplasia I-III, and invasive cervical cancer histopa- thology were included. HPV was detected by PCR assay and all HPV-positive specimens were subjected to direct nucleotide sequencing.

Results: Our results demonstrated that the total prevalence of HPV was 92.5%. The five most common HPV types were HPV 16 (49.3%), 18 (14.8%), 6 (7.4%), 31 (4.1%), and 11 (2.7%). About the histopathological stage, HPV 16 and 18 were dominant in all studied groups. In cervical cancer, HPV 16 and 18 were detected in 60% and 20% of cases, respectively.

Conclusion: HPV 16 and 18 were the most common in cervical cancer in Iran.

Published
2024-06-21
Section
Articles